LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,345,440 | -15.4% | 623,255 | +1.7% | 0.00% | 0.0% |
| Q2 2023 | $44,169,325 | -7.0% | 612,612 | -5.1% | 0.00% | -33.3% |
| Q1 2023 | $47,487,246 | -45.3% | 645,558 | -50.3% | 0.00% | 0.0% |
| Q4 2022 | $86,828,510 | +6.0% | 1,299,828 | +36.6% | 0.00% | -40.0% |
| Q3 2022 | $81,918,000 | -15.3% | 951,318 | -12.2% | 0.01% | -16.7% |
| Q2 2022 | $96,707,000 | -21.3% | 1,083,917 | -0.7% | 0.01% | 0.0% |
| Q1 2022 | $122,816,000 | -10.4% | 1,091,793 | +23.0% | 0.01% | 0.0% |
| Q4 2021 | $137,061,000 | +7.1% | 887,353 | -3.4% | 0.01% | -14.3% |
| Q3 2021 | $127,925,000 | +13.5% | 918,213 | +6.8% | 0.01% | +16.7% |
| Q2 2021 | $112,751,000 | -5.5% | 859,448 | +9.8% | 0.01% | -14.3% |
| Q1 2021 | $119,332,000 | +3.0% | 782,760 | -32.8% | 0.01% | 0.0% |
| Q4 2020 | $115,898,000 | +25.1% | 1,165,390 | +19.9% | 0.01% | +16.7% |
| Q3 2020 | $92,615,000 | -18.0% | 971,627 | -3.8% | 0.01% | -25.0% |
| Q2 2020 | $112,990,000 | +24.0% | 1,010,188 | -19.4% | 0.01% | 0.0% |
| Q1 2020 | $91,101,000 | -30.3% | 1,252,758 | -0.1% | 0.01% | -11.1% |
| Q4 2019 | $130,750,000 | +3.4% | 1,253,712 | -1.3% | 0.01% | 0.0% |
| Q3 2019 | $126,484,000 | -5.9% | 1,270,690 | +8.0% | 0.01% | -10.0% |
| Q2 2019 | $134,350,000 | -17.2% | 1,176,963 | -8.8% | 0.01% | -23.1% |
| Q1 2019 | $162,230,000 | +19.0% | 1,290,508 | +28.4% | 0.01% | +8.3% |
| Q4 2018 | $136,370,000 | -42.2% | 1,004,934 | +16.8% | 0.01% | -33.3% |
| Q3 2018 | $236,084,000 | +25.1% | 860,111 | -5.6% | 0.02% | +12.5% |
| Q2 2018 | $188,672,000 | +20.2% | 910,727 | -4.2% | 0.02% | +23.1% |
| Q1 2018 | $156,953,000 | +18.5% | 950,289 | -1.8% | 0.01% | +18.2% |
| Q4 2017 | $132,481,000 | +14.2% | 967,527 | +13.5% | 0.01% | +10.0% |
| Q3 2017 | $116,055,000 | +17.8% | 852,417 | +5.0% | 0.01% | +11.1% |
| Q2 2017 | $98,529,000 | +9.5% | 811,632 | -4.5% | 0.01% | +12.5% |
| Q1 2017 | $89,995,000 | +4.3% | 850,274 | +0.2% | 0.01% | 0.0% |
| Q4 2016 | $86,269,000 | -3.0% | 848,993 | -2.6% | 0.01% | -11.1% |
| Q3 2016 | $88,947,000 | +1.2% | 871,581 | +18.3% | 0.01% | 0.0% |
| Q2 2016 | $87,904,000 | +17.3% | 737,003 | +5.3% | 0.01% | +12.5% |
| Q1 2016 | $74,940,000 | +8.8% | 699,788 | +10.1% | 0.01% | 0.0% |
| Q4 2015 | $68,885,000 | +36.2% | 635,378 | +7.6% | 0.01% | +33.3% |
| Q3 2015 | $50,587,000 | -17.1% | 590,600 | -2.3% | 0.01% | -14.3% |
| Q2 2015 | $61,018,000 | +22.2% | 604,727 | -6.6% | 0.01% | +40.0% |
| Q1 2015 | $49,917,000 | +40.2% | 647,336 | -3.2% | 0.01% | +25.0% |
| Q4 2014 | $35,600,000 | +17.0% | 669,065 | +3.4% | 0.00% | +33.3% |
| Q3 2014 | $30,417,000 | -14.6% | 647,311 | +13.2% | 0.00% | -25.0% |
| Q2 2014 | $35,632,000 | -10.1% | 571,984 | -3.0% | 0.00% | -20.0% |
| Q1 2014 | $39,646,000 | -1.5% | 589,471 | -39.5% | 0.01% | +66.7% |
| Q4 2013 | $40,260,000 | +22.1% | 974,705 | +27.9% | 0.00% | -25.0% |
| Q3 2013 | $32,980,000 | +72.8% | 762,001 | +49.4% | 0.00% | +100.0% |
| Q2 2013 | $19,091,000 | – | 510,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |